Removal of endocrine disrupting compounds in a lab-scale anaerobic/aerobic sequencing batch reactor unit

Environmental Technology (United Kingdom)

Volumn 35, Issue 9, 2014, Pages 1055-1063

  Muz, M ^a   Ak, S ^a   Komesli, O T ^a,b   Gokcay, C F ^a  

^a MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

^b ATATÜRK UNIVERSITY   (Turkey)

Author keywords

A O process; biodegradation; EDC; endocrine disrupting compounds; LC (ESI) MS MS; SBR; sequencing batch reactor

Indexed keywords

EFFLUENTS; ELECTROSPRAY IONIZATION; MICROBIOLOGY; SEWAGE TREATMENT PLANTS;

A/O PROCESS; EDC; ENDOCRINE DISRUPTING COMPOUND; LC (ESI)/MS/MS; SBR; SEQUENCING BATCH REACTORS;

BIODEGRADATION;

CARBAMAZEPINE; DILTIAZEM; ENDOCRINE DISRUPTOR; ESTRONE; PARACETAMOL; PHOSPHORUS; PHTHALIC ACID BENZYL BUTYL ESTER; PROGESTERONE;

ANOXIC CONDITIONS; BIODEGRADATION; DOMESTIC WASTE; ENDOCRINE DISRUPTOR; ENVIRONMENTAL FATE; IONIZATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; ORGANIC POLLUTANT; OXIC CONDITIONS; POLLUTANT REMOVAL; SEWAGE TREATMENT; SLUDGE;

AEROBIC BACTERIUM; ANAEROBIC BACTERIUM; ARTICLE; BATCH REACTOR; BIODEGRADATION; CHEMICAL OXYGEN DEMAND; EFFLUENT; ELECTROSPRAY MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY; NONHUMAN; SEQUENCING BATCH REACTOR; SEWAGE TREATMENT PLANT; WASTE WATER; WASTE WATER MANAGEMENT;

ACETAMINOPHEN; ADSORPTION; BIOREACTORS; CARBAMAZEPINE; DILTIAZEM; ENDOCRINE DISRUPTORS; ESTRONE; PHTHALIC ACIDS; PROGESTERONE; SEWAGE; WASTE WATER; WATER POLLUTANTS, CHEMICAL;

EID: 84894053252     PISSN: 09593330     EISSN: 1479487X     Source Type: Journal    
DOI: 10.1080/09593330.2013.861020     Document Type: Article

References (43)

1. Damstra T, Barlow S, Bergman A, Kavlock R, Kraak GV. Global assessment of the state of the science of endocrine disruptors. WHO: IPCS - International Programme on Chemical Safety, 2002, [cited 2013 Apr]. Available from: http://www.who.int/ipcs/publications/new-issues/endocrine-disruptors/en/.
2. Heberer T. Tracking persistent pharmaceutical residues from municipal sewage to drinking water. J Hydrol. 2002;266:175-189.
3. Joss A, Siegrist H, Ternes TA. Are we about to upgrade wastewater treatment or removing organic micropollutants? Water Sci Technol. 2008;57:251-255.
4. Nakada N, Tanishima T, Shinohara H, Kiri K, Takada H. Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment. Water Res. 2006;40:3297-3303.
5. Stangroom SJ, Collins CD, Lester JN. Sources of organic micropollutants to lowland rivers. Environ Technol. 1998;19:643-666.
6. Birkett JW, Lester JN. Endocrine disrupters in wastewater and sludge treatment processes. London: IWA Publishing; 2003.
7. Petrovic M, Barcelo D. Determination of anionic and nonionic surfactants, their degradation products, and endocrine-disrupting compounds in sewage sludge by liquid chromatography/mass spectrometry. Anal Chem. 2000;72:4560-4567.
8. Kelvin KY. An evaluation of the factors controlling biodegradation of endocrine disrupting chemicals during wastewater treatment [PhD diss.]. London: Imperial College London; 2008.
9. Yoon Y, Westerhoff P, Snyder SA, Wert EC, Yoon J. Removal of endocrine disrupting compounds and pharmaceuticals by nanofiltration and ultrafiltration membranes. Desalination. 2007;202:6-23.
10. Braeken L, Van Der Bruggen B. Feasibility of nanofiltration for the removal of endocrine disrupting compounds. Desalination. 2009;240:127-131.
11. Boehler M, Zwickenpflug B, Hollender J, Ternes T, Joss A, Siegrist H. Removal of micropollutants in municipal wastewater treatment plants by powder-activated carbon. Water Sci Technol. 2012;66:2115-2121.
12. Serrano D, Suarez S, Lema JM, Omil F. Removal of persistent pharmaceutical micropollutants from sewage by addition of PAC in a sequential membrane bioreactor. Water Res. 2011;45:5323-5333.
13. Ifelebuegu AO, Lester JN, Churchley J, Cartmell E. Removal of and endocrine disrupting chemical (17alphaethinyloestradiol) from wastewater effluent by activated carbon adsorption: effects of activated carbon type and competitive adsorption. Environ Technol. 2006;27:1343-1349.
14. Bolong N, Ismail AF, Salim MR, Matsuura T. Areview of the effects of emerging contaminants in wastewater and options for their removal. Desalination. 2009;239:229-246.
15. Zhang H, Yamada H, Tsuno H. Removal of endocrinedisrupting chemicals during ozonation of municipal sewage with brominated byproducts control. Environ Sci Technol. 2008;42:3375-3380.
16. Muz M, Ak MS, Komesli OT, Gökcay CF. An ozone assisted process for treatment of EDC's in biological sludge. Chem Eng J. 2013;217:273-280.
17. Kim SE, Park NS, Yamada H, Tsuno H. Modeling of decomposition characteristics of estrogenic chemicals during ozonation. Environ Technol. 2008;29:287-296.
18. Li YM, Zeng QL, Yang SJ. Removal and fate of estrogens in an anaerobic-anoxic-oxic activated sludge system. Water Sci Technol. 2011;63:51-56.
19. Pholchan P, Jones M, Donnelly T, Sallis PJ. Fate of estrogens during the biological treatment of synthetic wastewater in a nitrite-accumulating sequencing batch reactor. Environ Sci Technol. 2008;42:6141-6147.
20. Tomei M, Annesini M. 4-Nitrophenol biodegradation in a sequencing batch reactor operating with aerobic-anoxic cycles. Environ Sci Technol. 2005;39:5059-5065.
21. Zhou Y, Huang X, Zhou H, Chen J, Xue W. Removal of typical endocrine disrupting chemicals by membrane bioreactor: in comparison with sequencing batch reactor. Water Sci Technol. 2011;64:2096-2102.
22. Kong X, Li D, Cao L, Zhang X, Zhao Y, Lv Y, Zhang J. Evaluation of municipal sewage treatment systems for pollutant removal efficiency by measuring levels of micropollutants. Chemosphere. 2008;72:59-66.
23. Koh YKK, Chiu TY, Boobis A, Cartmell E, Scrimshaw MD, Lester JN. Treatment and removal strategies for estrogens from wastewater. Environ Technol. 2008;29:245-267.
24. Reif R, Suárez S, Omil F, Lema JM. Fate of pharmaceuticals and cosmetic ingredients during the operation of a MBR treating sewage. Desalination. 2008;221:511-517.
25. Serrano D, Lema JM, Omil F. Influence of the employment of adsorption and coprecipitation agents for the removal of PPCPs in conventional activated sludge (CAS) systems. Water Sci Techol. 2010;62:728-735.
26. Metcalf L, Eddy H, Tchobanoglous G. Wastewater engineering: treatment, disposal, and reuse. New York: McGraw-Hill; 2004.
27. Sönmez MS, Muz M, Komesli OT, Bakirdere S, Gökcay CF. Determination of selected endocrine disrupter compounds at trace levels in sewage sludge samples. Clean. 2012;40:980-985.
28. Muz M, Sönmez MS, Komesli OT, Bakýrdere S, Gökçay CF. Determination of selected natural hormones and endocrine disrupting compounds in domestic wastewater treatment plants by liquid chromatography electrospray ionization tandem mass spectrometry after solid phase extraction. Analyst. 2012;137:884-889.
29. Gros M, Petrovic M, Ginebreda A, Barcelo D. Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes. Environ Int. 2010;36:15-26.
30. Roslev P, Vorkamp K, Aarup J, Frederiksen K, Nielsen PH. Degradation of phthalate esters in an activated sludge wastewater treatment plant. Water Res. 2007;41:969-976.
31. Lindemann K. Biodegradation of progesterone in surface water [PhD diss.]. Berlin: Frei Universität; 2006.
32. Schröder HF, Tambosi JL, Sena RF, Moreira RF, Jose HJ. The removal and degradation of pharmaceutical compounds during membrane bioreactor treatment. Water Sci Technol. 2012;65:833-839.
33. Thayanukul P, Zang K, Janhom T, Kurisu F, Kasuga I, Furumai H. Concentration-dependent response of estronedegrading bacterial community in activated sludge analyzed by microautoradiography-fluorescence in situ hybridization. Water Res. 2010;44:4878-4887.
34. Kanda R, Churchley J. Removal of endocrine disrupting compounds during conventional wastewater treatment. Environ Technol. 2008;29:315-323.
35. Mes T, Zeeman G, Lettinga G. Occurrence and fate of estrone, 17b-estradiol and 17a-ethynylestradiol in STPs for domestic wastewater. Rev Environ Sci Biotechnol. 2005;4:275-311.
36. Kasprzyk-Hordern B, Dinsdale RM, Guwy AJ. Illicit drugs and pharmaceuticals in the environment - Forensic applications of environmental data, Part 2: Pharmaceuticals as chemical markers of faecal water contamination. Environ Pollut. 2009;157:1778-1786.
37. Xue W, Wu C, Xiao K, Huang X, Zhou H, Tsuno H, Tanaka H. Elimination and fate of selected microorganic pollutants in a full-scale anaerobic/anoxic/ aerobic process combined with membrane bioreactor for municipal wastewater reclamation. Water Res. 2010;44:5999-6010.
38. Ifelebuegu AO. The fate and behavior of selected endocrine disrupting chemicals in full scale wastewater and sludge treatment unit processes. Int J Environ Sci Technol. 2011;8:245-254.
39. Stamatelatou K, Frouda C, Fountoulakis M, Drillia P, Kornaros M, Lyberatos G. Pharmaceuticals and health care products in wastewater effluents: the example of carbamazepine. Water Sci Technol. 2003;3:131-137.
40. Drillia P, Stamatelatou K, Lyberatos G. Fate and mobility of pharmaceuticals in solid matrices. Chemosphere. 2005;60:1034-1044.
41. Ternes TA, Herrmann N, Bonerz M, Knacker T, Siegrist H, Joss A. A rapid method to measure the solid-water distribution coefficient (Kd) for pharmaceuticals and musk fragrances in sewage sludge. Water Res. 2004;38:4075-4084.
42. Maoz A, Chefetz B. Sorption of the pharmaceuticals carbamazepine and naproxen to dissolved organic matter: role of structural fractions. Water Res. 2010;44:981-989.
43. Radjenovic J, Petrovic M, Barcelo D. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. Water Res. 2009;43:831-841.